Based on the Inogen Inc stock forecast from 0 analysts, the average analyst target price for Inogen Inc is not available over the next 12 months. Inogen Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Inogen Inc is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Inogen Inc’s stock price was USD 6.88. Inogen Inc’s stock price has changed by +0.00% over the past week, -6.39% over the past month and -0.29% over the last year.
No recent analyst target price found for Inogen Inc
No recent average analyst rating found for Inogen Inc
Company Overview Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. Read Less
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from ...Read More
Frequently Asked Questions About Inogen Inc (INGN) Stock
Stock Target Advisor's fundamental analysis for Inogen Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on INGN's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on INGN's stock to indicate what its average analyst target is.
INGN stock's Price/Earning ratio is 51.51.
Our analysis grades INGN stock's Price / Earning ratio at F. This means that INGN stock's Price/Earning ratio is above 74% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this INGN may be a overvalued for its sector.
The last closing price of INGN's stock was USD 6.88.
The most recent market capitalization for INGN is USD 0.18B.
Unfortunately we do not have enough analyst data on INGN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Inogen Inc's stock.
As per our most recent records Inogen Inc has 766 Employees.
Inogen Inc's registered address is 859 Ward Drive, Goleta, CA, United States, 93111.
You can get more information about it from Inogen Inc's website at https://provider.inogen.com/en.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Inogen Inc (INGN) Stock
Stock Target Advisor's fundamental analysis for Inogen Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on INGN's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on INGN's stock to indicate what its average analyst target is.
INGN stock's Price/Earning ratio is 51.51.
Our analysis grades INGN stock's Price / Earning ratio at F. This means that INGN stock's Price/Earning ratio is above 74% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this INGN may be a overvalued for its sector.
The last closing price of INGN's stock was USD 6.88.
The most recent market capitalization for INGN is USD 0.18B.
Unfortunately we do not have enough analyst data on INGN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Inogen Inc's stock.
As per our most recent records Inogen Inc has 766 Employees.
Inogen Inc's registered address is 859 Ward Drive, Goleta, CA, United States, 93111.
You can get more information about it from Inogen Inc's website at https://provider.inogen.com/en.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for INGN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
